CURE was live on site at the the 19th Annual New York GU Cancers Congress®, where we spoke with Dr. Ulka Vaishampayan on the ...
For many people diagnosed with colorectal cancer, surgery can bring lifesaving treatment but also lasting changes.
An ipsilateral breast cancer recurrence after long disease-free interval may still permit curative-intent local therapy, with ...
Dr. Anastasia Tousimis explores the feasibility, risks and surgical techniques for performing NSM in radiated patients to ...
Among patients on q2-week chemotherapy, exercise significantly reduced overall cognitive decline, perceived cognitive impairment, and mental fatigue versus usual care. Attenuated effects with ...
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...
Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...
Eyelashes provide biomechanical ocular surface protection by sensing debris and triggering the blink reflex, reducing ...
In the rapidly shifting landscape of multiple myeloma treatment, the roadmap for a patient diagnosed in 2026 looks vastly different than it did even a decade ago. In a recent interview with CURE, Dr.
A major obstacle is the blood-brain barrier, which Kunwar described as similar to “Saran Wrap” surrounding every blood vessel in the brain. This barrier evolved to protect the brain from foreign ...
explained that getting drugs into the brain is a major hurdle for glioblastoma, as the blood-brain barrier blocks most treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results